Loading…
← CockpitCompetitor Analysis › 603976.SS Chongqing Zhengchuan Pharmaceutical Packaging Co. Ltd. Class AOpen in the cockpit ↗

Chongqing Zhengchuan Pharmaceutical Packaging Co. Ltd. Class A603976.SSCompetitor analysis, valuation and peers

China · CNY·Consumer Discretionary›Home Furnishings
Momentum leader 98
Mkt cap
$769M
US dollars, full cap
Free float
98%
of shares outstanding
$/day
$21.2M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-5.4 pp
WACC 6.5%
Hurdle
+45 pp
Req g minus delivered
Close · CNYCN¥29.87
1D-3.9%
1W+2.2%
1M+2.1%
3M+23.3%
6M+41.2%
YTD+54.5%
1Y+49.6%
ATR %6.1%
52w lowhigh19.7% off high

What Chongqing Zhengchuan Pharmaceutical Packaging does

Employees: 1,361

Chongqing Zhengchuan Pharmaceutical Packaging at a glance

Size Chongqing Zhengchuan Pharmaceutical Packaging (603976.SS) is a China Consumer Discretionary company (Home Furnishings) with a market value of $769M, the 2856th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥29.87 on 6 Nov 2026.

Performance Over six months the shares gained 41.2%, against -14.3% for the median peer and -16.4% for the China market (cap-weighted) — 3rd highest of 21 in its peer set.

Growth Revenue grew 8.6% over the last twelve months (peer median -0.1%); the operating margin is 3.1% (peer median 3.5%).

Valuation It trades at 7.4× enterprise value to sales against a peer median of 2.9× (3rd most expensive of 21).

Price implies For today's price to make sense, revenue must grow about 51% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +45 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 5.4 points below its cost of capital (6.5% WACC).

Relative performance

10015011 May 202611 Aug 20266 Nov 2026603976.SS 140Peer median 84
Six months, rebased to 100: Chongqing Zhengchuan Pharmaceutical Packaging against the median of its 20 peers (local-currency closes).

Chongqing Zhengchuan Pharmaceutical Packaging financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥721MCN¥661MCN¥799MCN¥890MCN¥787M
Revenue growth—-17%-10%+13%—
Gross profitCN¥105MCN¥108MCN¥150MCN¥117MCN¥143M
EBITDACN¥137MCN¥134MCN¥185MCN¥158MCN¥154M
Net incomeCN¥17.1MCN¥18.9MCN¥53.2MCN¥40.3MCN¥64.8M
Free cash flowCN¥96.5MCN¥112MCN¥43.2MCN¥110M-CN¥229M
Capital expenditureCN¥61.0MCN¥27.1MCN¥72.0MCN¥90.0MCN¥276M
Total debtCN¥558MCN¥538MCN¥566MCN¥613MCN¥586M

Quarterly statements and history in the cockpit →

Chongqing Zhengchuan Pharmaceutical Packaging competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%+40%-20%0%+20%002489001216003041CELLOHELETTKPRESTIGCERA603365600337603838301055300749603898603610002713603313002572002853001323603976.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Chongqing Zhengchuan Pharmaceutical Packaging is the large dot.

Fundamentals: revenue growth against valuation

-20%0%0×5×10×002489001216003041CELLOHELETTKPRESTIGCERA600337603838301055002571300749603898603610002713002572002853001323603976.SSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Chongqing Zhengchuan Pharmaceutical Packaging is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%CELLOHELETTKPRESTIGCERA603365603610603313002572001323603976.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Chongqing Zhengchuan Pharmaceutical Packaging is the large dot.

Chongqing Zhengchuan Pharmaceutical Packaging competitors and peer comparison

How Chongqing Zhengchuan Pharmaceutical Packaging compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Chongqing Zhengchuan Pharmaceutical Packaging against its 20 peers (data as of 6 Nov 2026)
Measure603976.SSPeer medianRank in peer set
1-month return+2.1%-6.0%5th highest of 21
6-month return+41.2%-14.3%3rd highest of 21
Distance from 52-week high-19.7%-41.4%5th highest of 21
Revenue growth (TTM)+8.6%-0.1%5th highest of 21
Operating margin3.1%3.5%11th highest of 21
EV / Sales7.4×2.9×3rd most expensive of 21
Growth the price implies (Req g, 7 yrs)51.0%7.1%most demanding of 11
Growth delivered (Del g)+6.0%+6.3%4th lowest of 11
Hurdle (Req g minus delivered)+45.0 pp+5.6 ppmost demanding of 11
ROIC minus cost of capital-5.4 pp-2.8 pp9th lowest of 21
EV / EBITDA39.1×18.7×most expensive of 5
Net debt / EBITDA1.7×-1.8×3rd most indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Chongqing Zhengchuan Pharmaceutical Packaging 603976.SSChina$769M+41%+9%3%7.4×51.0%+6.0%
Yotrio 002489.SZChina$809M-23%0%2%0.9×n/an/a
Hunan Hualian China Industry 001216.SZChina$729M-9%-15%12%3.2×n/an/a
Zhejiang Truelove Vogue 003041.SZChina$698M-38%-1%7%5.2×n/an/a
Cello World CELLO.NSIndia$870M-14%+7%16%3.5×28.6%+17.2%
Helen of Troy HELEUnited States$876M+51%+1%7%0.9×3.9%-3.1%
TTK Prestige TTKPRESTIG.NSIndia$882M+14%+16%7%2.6×36.8%+6.3%
Cera Sanitaryware CERA.NSIndia$654M-12%+15%10%2.4×21.9%+10.7%
Shanghai Shuixing Home Textile 603365.SSChina$621M-29%+2%10%0.7×-12.9%+8.2%
Markor International Home Furnishings 600337.SSChina$613M+19%-43%-106%3.3×n/an/a
Guang Dong Sitong 603838.SSChina$612M+43%+8%-23%10.0×n/an/a
Zhang Xiaoquan 301055.SZChina$597M-13%+15%5%3.1×27.1%+12.4%
Anhui Deli Household Glass 002571.SZChina$574M-15%-16%-10%3.2×n/an/a
GuangDong Topstrong Living Innovation & Integration 300749.SZChina$570M-24%-34%-13%6.5×n/an/a
Guangzhou Holike Creative Home 603898.SSChina$555M-7%-21%-5%2.0×n/an/a
Keeson Technology 603610.SSChina$550M-39%+11%2%1.2×10.4%+6.1%
Dong Yi Ri Sheng Home Decoration 002713.SZChina$1.08B-38%-1%-23%9.6×n/an/a
Healthcare 603313.SSChina$533M-2%+4%2%0.7×-9.0%+6.4%
Suofeiya Home Collection 002572.SZChina$1.12B-35%-22%8%1.1×-2.8%+2.3%
Guangdong Piano Customized Furniture 002853.SZChina$520M-30%-30%-23%7.1×n/an/a
De Rucci Healthy Sleep 001323.SZChina$1.15B-26%-6%5%1.3×0.0%+3.3%

Questions

Which companies are Chongqing Zhengchuan Pharmaceutical Packaging's closest peers?
The cockpit's peer set: Yotrio (002489.SZ), Hunan Hualian China Industry (001216.SZ), Zhejiang Truelove Vogue (003041.SZ), Cello World (CELLO.NS), Helen of Troy (HELE), TTK Prestige (TTKPRESTIG.NS), Cera Sanitaryware (CERA.NS), Shanghai Shuixing Home Textile (603365.SS).
Is Chongqing Zhengchuan Pharmaceutical Packaging expensive compared with its peers?
On ev / sales it trades at 7.4× against a peer median of 2.9×, 3rd most expensive of 21 in its peer set. For today's price to make sense, revenue must grow about 51% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +45 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Chongqing Zhengchuan Pharmaceutical Packaging stock performed?
Over six months to 6 Nov 2026 the shares returned +41.2% against -14.3% for the median peer; over one year +49.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.